Tickerplace logo

Tickerplace

Bone Biologics Corporation logo

BBLGBone Biologics Corporation

BBLG Stock Price, Valuation & Chart | Bone Biologics Corporation

Compare
$0.570+0.01 (+1.70%)

At close · 02 Sept 2026, 07:59 pm

Sector: HealthcareIndustry: Medical - DevicesBBLG intrinsic valueBBLG calculated fair value vs price
OverviewFinancialsDividendsRatios

BBLG Historical price chart

BBLG Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization1.04M
PE Ratio-0.25
EPS-2.27
Trading Volume95.25K
Today's High/Low0.56/0.54
Dividend Yield0.00
52 Week High/Low4.13/0.54
Shares Outstanding1.81M
BBLG Financial Statement
BBLG Analyst ratings
BBLG Analysis & performance metrics

BBLG Company profile

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a…

BBLG Management team

Management
Deina H. Walsh CPACFO
Chief Financial Officer
Jeffrey FrelickCEO
Chief Executive Officer & President
Total 2 executives

BBLG Frequently asked questions

What is Bone Biologics Corporation (BBLG) Stock Price?

Current stock price of Bone Biologics Corporation (BBLG) stock is $0.570. The stock price is +1.70% higher in the session. The intraday range can be seen from this page. Volume of Bone Biologics Corporation (BBLG) stock is 95.25K.

Last updated at 02 Sept 2026, 07:59 pm.

Why is the Bone Biologics Corporation (BBLG) stock price going up or down today?

The stock price of Bone Biologics Corporation (BBLG) can change with earnings, company news, and overall market sentiment. Bone Biologics Corporation operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Bone Biologics Corporation stock expensive at its current price?

Whether Bone Biologics Corporation looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BBLG on this page is -0.25. EPS on this page is -2.27. Compare those figures with peers and growth expectations before deciding if the current Bone Biologics Corporation price is justified.

How has the stock price of Bone Biologics Corporation (BBLG) performed historically?

Historical performance for Bone Biologics Corporation (BBLG) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BBLG reacted to past earnings and market events.

Should I buy Bone Biologics Corporation (BBLG) stock, at this price?

Buying Bone Biologics Corporation (BBLG) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.